Valiant Laboratories Ltd.

View in App
184.35 -0.75 ▼-0.4%

29 November 2023, 04:00:00 PM
Volume: 27,062

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.valiantlabs.in
Market Cap 801.00 Cr.
Enterprise Value(EV) 861.97 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 6.67 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 27.62 Trailing Twelve Months Ending 2023-03
Industry PE 37.97 Trailing Twelve Months Ending 2023-03
Book Value / Share 59.38 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.10 Calculated using Price: 184.35
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 4.35 Cr. 43,450,000 Shares
FaceValue 10
About Valiant Laboratories Ltd.
Valiant Laboratories is a leading Active Pharmaceutical ingredient manufacturing company with its focus on manufacturing Paracetamol API/Bulk Drug which has several applications like uses in treatment of conditions such as headache, muscle ache, arthritis, back ache, toothache, cold and fever.

Valiant Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Valiant Laboratories Ltd. Performance

View details >>
1 Day
-0.41%
1 Week
+0.85%
1 Month
-2.92%
3 Month
6 Month
1 Year
2 Year
5 Year
10 Year

Valiant Laboratories Ltd. Fundamental Ratios

View details >>
1 years 2023-03
Return on Equity (%) 28.86
Return on Capital Employed (%) 24.01
Return on Assets (%) 13.62

Valiant Laboratories Ltd. Balance Sheet

View details >>
Particulars 2 years 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 100 106
Non Curr. Liab. 62 62
Curr. Liab. 51 48
Minority Int.
Equity & Liab. 213 215
Non Curr. Assets 62 83
Curr. Assets 151 132
Misc. Exp. not W/O
Total Assets 213 215

Valiant Laboratories Ltd. Profit and Loss

View details >>
Particulars 1 years 2023-03 Rs. Cr.
Net Sales 334
Other Income 5
Total Income 339
Total Expenditure -299
PBIDT 40
Interest 0
Depreciation -2
Taxation -9
Exceptional Items
PAT 29
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 29
Adjusted EPS 9

Valiant Laboratories Ltd. Cash Flow

View details >>
Particulars 1 years 2023-03 Rs. Cr.
Cash Fr. Operatn. 56
Cash Fr. Inv. -55
Cash Fr. Finan. -1
Net Change 0
Cash & Cash Eqvt 1

Valiant Laboratories Ltd. Shareholding Pattern

View details >>
1 Qtrs 2023-09 (%)
Promoter 74.94
Public 25.06
Depository Receipts 0.00
Promoter Holding Pledge (%) 0.00

Valiant Laboratories Ltd. Announcements

View details >>
Mon, 27 Nov 2023
Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 (LODR)- Credit rating
Wed, 08 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Financial Results for quarter and half year ended September 30 2023.
Mon, 30 Oct 2023
Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30 2023.
Valiant Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Audited Financial Results for the Quarter and Half Year ended September 30 2023.

Valiant Laboratories Ltd. Technical Scans

View details >>
Tue, 28 Nov 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High

Valiant Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 285,856.77 1,202.20 +0.9%
Divi's Laboratories Ltd. 99,768.40 3,723.50 -0.9%
Cipla Ltd. 96,240.20 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. 94,596.57 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. 77,163.47 5,437.10 +1.3%
Mankind Pharma Ltd. 75,957.58 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. 70,389.88 2,089.90 +0.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 33.44 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 74.91 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 27.87 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.58 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 110.63 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 59.26 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.77 2,089.90 +0.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.78 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-09 7.87 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-09 3.88 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.71 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 11.87 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 9.01 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.49 2,089.90 +0.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 0.02 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 12.85 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,089.90 +0.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,089.90 +0.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,202.20 +0.9%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,723.50 -0.9%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,201.55 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,719.85 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,437.10 +1.3%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,898.60 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,089.90 +0.5%

Valiant Laboratories Ltd. FAQ's

What is Valiant Laboratories share price?
Can I buy Valiant Laboratories shares now?
What is the Market Cap of Valiant Laboratories?
What are the key metrics to analyse Valiant Laboratories?
What is the 52 Week High and Low of Valiant Laboratories?
What is the trend of Valiant Laboratories share price?